AKT1 and Insulin resistance: Mutant forms of FAK impair insulin signalling in HepG2 cells [18] and tail-vein injection of siRNA against the FAK gene (PTK2) leads to insulin resistance, concomitant with reduced protein kinase B (PKB, also known as Akt) phosphorylation in mouse models of diabetes [9].